COLO B Coloplast A/S Class B

Coloplast A/S – Updated presenters list for Capital Markets Day on 2 September 2025

Coloplast A/S – Updated presenters list for Capital Markets Day on 2 September 2025

Following the changes to the Executive Leadership Team, announced on 19.08.2025*, we are pleased to share with you the updated presenters list for our Capital Markets Day on 2 September 2025. For those of you who have signed up, we look forward to seeing you at the event. 

The event will take place on Tuesday, 2 September 2025 at Clarion Hotel (Copenhagen airport)

Ellehammersvej 20, 2770 Kastrup

from 10.30 - 17.00 CEST

(Central European Summer Time)

The event will be held in person at Clarion Hotel in Copenhagen, Denmark, with the option to join virtually for the plenary session. A link for the webcast of the plenary sessions will be available on our website closer to the date.​ 

The purpose of the event is to give institutional investors and financial analysts an introduction to the new 5-year strategy for the company, as well as to provide the opportunity to meet with the broader Management team.

The day will start with a plenary session, covering the introduction of the new Group strategy, a financial update, and the strategy for the Chronic Care businesses. In the afternoon, participants will be split into groups and rotate between four Q&A breakout sessions. Participation in the breakout sessions will be in-person only (with a replay of the presentations available after the event).

The formal program will end at 17.00, followed by an opportunity to meet the Coloplast management team in an informal setting.

Agenda in CEST

10.00 - 10.30  Registration

10.30 - 12.30  Plenary session: Group strategy and financials, Chronic Care Commercial strategy

12.30 - 13.00  Lunch break

13.00 - 17.00  Q&A breakout sessions (incl. breaks)

17.00 - 18.30  Social activity (on premise)

Coloplast representatives

Plenary session:  

  Lars Rasmussen, Interim President and CEO

  Anders Lonning-Skovgaard, Executive Vice President, CFO

  Caroline Vagner Rosenstand, Executive Vice President, Chronic Care Commercial 

Breakout sessions:  

  Chronic Care deep dive:

  Mike DelVacchio, Senior Vice President, North America

  Thomas Bruhn, Senior Vice President, Emerging Markets

  Wound & Tissue Repair:

  Fertram Sigurjonsson, Executive Vice President, Wound & Tissue Repair

  Bernd Greiner, Senior Vice President, Adv. Wound Dressings

  Interventional Urology:

  Thomas NP Johns Jr, Executive Vice President, Interventional Urology

  Global Operations and People & Culture:

  Allan Rasmussen, Executive Vice President, Global Operations

  Dorthe Rønnau, Executive Vice President, People & Culture

 * 

For more information,

please contact:

Aleksandra Dimovska, Vice President

Direct tel.:

E-mail: 

 

Kristine Husted Munk, Sr. Manager

Direct tel.:

E-mail:

Simone Dyrby Helvind, Sr. Manager  

Direct tel.:

E-mail:  

Julie Sommer Müggler, Coordinator   

Direct tel.:

Email:  

Attachment



EN
19/08/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Coloplast A/S Class B

 PRESS RELEASE

Coloplast A/S - FY 2024/25 Earnings Release - Invitation for conferenc...

Coloplast A/S - FY 2024/25 Earnings Release - Invitation for conference call on 4 Nov 2025 at 11.00 CET Tuesday, 4 November 2025 at 11:00 - 12:00am CETIn connection with the publication of Coloplast’s interim financial results for FY 2024/25, to be released same day around 07.00am CET, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast’s website approximately 1 hour before the conference call.The webcast of the conference call will be available during and after the ...

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
 PRESS RELEASE

Coloplast interim CEO Lars Rasmussen udtræder af bestyrelsen ved den k...

Coloplast interim CEO Lars Rasmussen udtræder af bestyrelsen ved den kommende ordinære generalforsamling Selskabsmeddelelse nr. 09/2025Intern viden Coloplast interim CEO Lars Rasmussen udtræder af bestyrelsen ved den kommende ordinære generalforsamling Interim CEO Lars Rasmussen har i dag informeret Coloplasts bestyrelse om, at han ikke genopstiller som bestyrelsesmedlem ved den kommende ordinære generalforsamling den 4. december 2025. ”På vegne af bestyrelsen vil jeg gerne takke Lars for hans mangeårige engagement i Coloplast. Gennem næsten fire årtiers virke – herunder 10 år som CEO og...

 PRESS RELEASE

Coloplast interim CEO Lars Rasmussen will step down from the Board at ...

Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting Announcement no. 09/2025Inside information   Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting  Coloplast interim CEO Lars Rasmussen has today informed the Coloplast Board of Directors that he will not stand for re-election as board member at the upcoming annual general meeting on December 4, 2025.   “On behalf of the Board, I want to thank Lars for his unwavering dedication to Coloplast. Through his commitment to the company f...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch